Activation of the cholinergic anti-inflammatory pathway reduces NF-κB activation, blunts TNF-α production, and protects against splanchnic artery occlusion shock

Shock

Volumn 25, Issue 5, 2006, Pages 500-506

  Altavilla, Domenica ^a   Guarini, Salvatore ^b   Bitto, Alessandra ^a   Mioni, Chiara ^b   Giuliani, Daniela ^b   Bigiani, Albertino ^b   Squadrito, Giovanni ^c   Minutoli, Letteria ^a   Venuti, Francesco S ^c   Messineo, Francesco ^c   De Meo, Vincenzo ^c   Bazzani, Carla ^b   Squadrito, Francesco ^a,c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

NF B; Sao shock; TNF ; Vagus nerve stimulation

Indexed keywords

CHLORISONDAMINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MYELOPEROXIDASE; NICOTINIC RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ILEUM; INFLAMMATION; LIVER; MALE; NONHUMAN; RAT; SHOCK; SPLANCHNIC BLOOD FLOW; SURVIVAL RATE; TREATMENT OUTCOME; VAGUS NERVE STIMULATION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTERIAL OCCLUSIVE DISEASES; CHLORISONDAMINE; ELECTRIC STIMULATION; I-KAPPA B PROTEINS; MALE; NF-KAPPA B; NICOTINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHOLINERGIC; SHOCK; SPLANCHNIC CIRCULATION; TUMOR NECROSIS FACTOR-ALPHA; VAGUS NERVE;

EID: 33646816058     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000209539.91553.82     Document Type: Article

References (30)

1. Squadrito F, Altavilla D, Squadrito G, Ferlito M, Deodato B, Arlotta M, Minutoli L, Campo GM, Bova A, Quartarone C, et al: Protective effects of cyclosporin-A in splanchnic artery occlusion shock. Br J Pharmacol 130:339-344, 2000.
2. Squadrito F, Guarini S, Altavilla D, Squadrito G, Campo GM, Arlotta M, Quartarone C, Saitta A, Cucinotta D, Bazzani C, et al: Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock. Br J Pharmacol 128:816-822, 1999.
3. Squadrito F, Altavilla D, Squadrito G, Ferlito M, Campo GM, Arlotta M, Grimaldi S, Quartarone C, Saitta A, Caputi AP: Tacrolimus suppresses tumour necrosis factor-α and protects against splanchnic artery occlusion shock. Br J Pharmacol 127:498-504, 1999.
4. Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Quartarone C, Saitta A, Caputi AP: Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock. Br J Pharmacol 127:482-488, 1999.
5. Squadrito F, Altavilla D, Deodato B, Squadrito G, Ferlito M, Arlotta M, Minutoli L, Bova A, Caputi AP: Early activation of transcription factor NF-κB in splanchnic artery occlusion shock. In: Faist (eds.) Trauma, Shock, Inflammation and Sepsis: Pathophysiology, Immune Consequences and Therapy. 5th World Congress Munich (Germany), February 29-March 4. Ed. Monduzzi 389-394, 2000.
6. Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Arcoraci V, Minutoli L, Saitta A, Caputi AP: The involvement of tumour necrosis factor-alpha in the protective effects of 17 β oestradiol in splanchnic ischaemia-reperfusion injury. Br J Pharmacol 121:1782-1788, 1997.
7. Altavilla D, Squadrito F, Canale P, Ioculano M, Campo GM, Squadrito G, Saitta A, Caputi AP: Tumor necrosis factor induces E-selectin production in splanchnic artery occlusion shock. Am J Physiol 268:H1412-H1417, 1995.
8. Canale P, Squadrito F, Altavilla D, Ioculano M, Zingarelli B, Campo GM, Urna G, Sardella A, Squadrito G, Caputi AP: TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock. Agents and Actions 42:128-134, 1994.
9. Besedovsky H, del Rey A, Sorkin E, Dinarello CA: Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233:652-654, 1986.
10. Hu XX, Goldmuntz EA, Brosnan CF: The effect of norepinephrine on endotoxin mediated macrophage activation. J Neuroimmunol 31:35-42, 1991.
11. Lipton JM, Catania A: Antiinflammatory action of neuroimmunomodulator α-MSH. Immunol Today 18:140-145, 1997.
12. Watkins LR, Maier SF: Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci USA 96:7710-7713, 1999.
13. Sternberg EM: Neural-immune interactions in health and disease. J Clin Invest 100:2641-2647, 1997.
14. Scheimann RI, Cogswell PC, Lofquist AK, et al: Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283-286, 1995.
15. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458-462, 2000.
16. Guarini S, Altavilla D, Cainazzo MM, Giuliani D, Bigiani A, Marini H, Squadrito G, Minutoli L, Bertolini A, Marini R, et al: Efferent vagal fiber stimulation blunts nuclear factor-κB activation and protects against hypovolemic hemorrhagic shock. Circulation 107:1189-1194, 2003.
17. Squadrito F, Altavilla D, Canale P, Ioculano M, Campo GM, Ammendolia L, Ferlito M, Zingarelli B, Squadrito G, Saitta A, et al: Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock. Br J Pharmacol 113:1153-1158, 1994.
18. Altavilla D, Saitta A, Guarini S, Galeano M, Squadrito G, Cucinotta D, Santamaria LB, Mazzeo AT, Campo GM, Ferlito M, et al: Oxidative stress causes nuclear factor-κB activation in acute hypovolemic hemorrhagic shock. Free Radic Biol Med 30:1055-1066, 2001.
19. Tracey KJ: The inflammatory reflex. Nature 420:853-859, 2002.
20. Chaudry IH, Ertel W, Ayala A: Alterations in inflammatory cytokine production following hemorrhage and resuscitation: In: G Schlag, H Redl, DL Traber, (eds.): Shock, sepsis and organ failure. Third Wiggers Bernard Conference. Berlin: Springer Verlag. 73-127, 1993.
21. Squadrito F, Altavilla D, Ioculano M, Calapai G, Zingarelli B, Saitta A, Campo GM, Rizzo A, Caputi AP: Passive immunization with antibodies against tumor necrosis factor (TNF-α) protects from the lethality of splanchnic artery occlusion shock. Circ Shock 37:236-244, 1992.
22. Bauerle PA, Baltimore D: NF-κB: ten years after. Cell 87:13-20, 1996.
23. Schmitz ML, Bauerle PA: Multi-step activation of NF-κB/rel transcriptional factors. Immunobiology 193:116-127, 1995.
24. Schreck R, Rieber P, Baeuerle P: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10:2247-2258, 1991.
25. May MJ, Ghosh S: Signal transduction through NF-κB. Immunol Today 19:81-88, 1998.
26. Borovikova LV, Ivanova S, Nardi D, Zhang M, Yang H, Ombrellino M, Tracey KJ: Role of vagus nerve signalling in CNI-1943-mediated suppression of acute inflammation. Auton Neurosci 85:141-147, 2000.
27. Bernik TR, Friedman SG, Ochani M, DiRaimo R, Ulloa L, Yang H, Sudan S, Czura CJ, Ivanova SM, Tracey KJ: Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 195:781-788, 2002.
28. Guarini S, Cainazzo MM, Giuliani D, Mioni C, Altavilla D, Marini H, Bigiani A, Ghiaroni V, Passaniti M, Leone S, et al: Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc Res 63:357-365, 2004.
29. Watkins SS, Stinus L, Koob GF, Markou A: Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther 292:1053-1064, 2000.
30. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, et al: Cholinergic agonists inhibits HMGB1 release and improve survival in experimental sepsis. Nat Med 10:1216-1221, 2004.